Market Overview

Bio-Rad Laboratories, Inc. (NYSE: BIO)

345.21 +5.01 (1.47%)

Analyst Ratings

DateResearch FirmActionCurrentPT
8/20/19Goldman SachsUpgradesConviction Buy400.0
5/09/19Deutsche BankMaintainsBuy375.0
5/09/19BarclaysMaintainsOverweight350.0
3/01/19Deutsche BankMaintainsBuy350.0
3/01/19BarclaysMaintainsOverweight340.0
1/03/19BarclaysUpgradesOverweight315.0
11/02/18BarclaysMaintainsEqual-Weight315.0
10/17/18Goldman SachsInitiates Coverage OnBuy350.0
9/20/18Morgan StanleyInitiates Coverage OnEqual-Weight335.0
9/05/18BarclaysInitiates Coverage OnEqual-Weight345.0

Data powered by Benzinga Pro Calendars - Start your FREE TRIAL today!

Sign up to receive Benzinga's Daily Ratings Newsletter